Alentis obtains IND clearance from FDA for CLDN1+ tumours treatment
The approval allows for the investigation of ALE.C04 both as a standalone treatment and in combination with pembrolizumab…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jun 23
The approval allows for the investigation of ALE.C04 both as a standalone treatment and in combination with pembrolizumab…
15 Jun 23
This strategic collaboration aims to revolutionize the field of genomics through the development of new scalable solutions for…
14 Jun 23
ACROBiosystems and US-based biosensor company Diagnostic Biochips will advance the neurological drug discovery and commercialisation, through their new…
14 Jun 23
The off-the-shelf packaging plasmids will also support the development of cell and gene therapies by offering quick availability,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Jun 23
The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug -…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Jun 23
The company will expand its existing Active Pharmaceutical Ingredient (API) production facility in Denmark for the future portfolio…
13 Jun 23
Signals Research Suite integrates workflows across biology, chemistry and materials new product development to arm scientists with better…
12 Jun 23
The ALPHA trial is designed to evaluate the efficacy and safety of danicopan as an add-on to C5…
12 Jun 23
The partnership intends to use in vivo electrophysiology solutions to drive neuroscience research and accelerate neurological drug discovery…
12 Jun 23
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during…